Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2014

View Archived Issues

Amniox Medical initiates clinical trial of placenta-derived diabetic foot ulcer therapy

Lion Biotechnologies enters into trial agreement with Moffitt Cancer Center

Dong Wha completes phase III study of zabofloxacin in patients with COPD

Kalydeco approved in Europe in CF for eight non-G551D gating mutations

FUJIFILM presents novel PI3K and ERK-2 inhibitors

Researchers at Xencor divulge new heterodimeric proteins

Cubist Pharmaceuticals discloses novel TRPA1 antagonists

Novel HCV NS5A inhibitors disclosed by Merck & Co.

Daiichi Sankyo recaps pipeline progress of first quarter of fiscal 2014

Janssen Pharmaceutica patents novel gamma-secretase modulators

Kyowa Hakko Kirin seeks approval in Japan for KW-3357

Esteve confirms initiation of natural history study for Sanfilippo A syndrome

OncoCyte expands clinical development of bladder cancer diagnostic

First-in-human and in vitro results presented on novel drug for pre-transplantation desensitization

AFFiRiS reports results from phase I trial of Affitope PD-01A

Chugai Pharmaceuticals reports progress during second quarter 2014

Regeneron and Sanofi to use priority review voucher for alirocumab BLA

Shionogi to sell Ezose Sciences to Sumitomo Bakelite

Cara Therapeutics initiates abuse potential trial for CR-845

FDA approves olodaterol for COPD

Cortice Biosciences to develop heart failure drug for cognitive impairment

CHBP and caspase-3 siRNAs for renoprotection against ischemia reperfusion and CsA nephrotoxicity

Solasia gains exclusive worldwide rights to darinaparsin from Ziopharm Oncology

Alexion's eculizumab obtains European orphan drug designation for myasthenia gravis

Phase III trial initiated by Isis Pharmaceuticals for ISIS-SMNRx in infants

FDA approves empagliflozin for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...